Jove
Visualize
お問い合わせ

関連する概念動画

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. Ptpn6の全がん分析:腫瘍進行における予後的意義と機能的影響
  1. ホーム
  2. Ptpn6の全がん分析:腫瘍進行における予後的意義と機能的影響

関連する実験動画

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K

PTPN6の全がん分析:腫瘍進行における予後的意義と機能的影響

Xiaohui Wang1, Mumtaz Hussain2, Qurat Ul Ain3

  • 1Department of Dentistry, Henan Provincial Key Medicine Laboratory of Nursing, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, 450003, Henan, China.

Discover oncology
|August 25, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

タンパク質チロシンフォスファターゼ非受容体型6 (PTPN6) はがんの進行を促進し,生存率の低下と関連しています. この研究では,PTPN6が潜在的な全がん予後バイオマーカーであり,治療目標であることが明らかになりました.

キーワード:
バイオマーカーパンガン予測治療方法

さらに関連する動画

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

関連する実験動画

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

科学分野:

  • 腫瘍学
  • 分子生物学
  • 癌 研究

背景:

  • 癌は複雑な分子変化によって引き起こされる 世界的な健康問題です
  • タンパク質チロシンフォスファタゼ非受容体タイプ6 (PTPN6) またはSHP-1は,免疫およびシグナル伝達経路に不可欠です.
  • PTPN6の腫瘍形成における役割,特にリンパ腫と白血病における腫瘍抑制剤としての役割は確立されていますが,その全がん機能は明確にする必要があります.

研究 の 目的:

  • PTPN6の全面的ながん分析を行う
  • PTPN6の予測的意義と様々な癌の分子機能を調査する.
  • PTPN6のバイオマーカーおよび治療標的としての可能性を調査する.

主な方法:

  • パンガン分析のために複数の公共データベースからデータを利用した.
  • 実験室での分子実験を行った.
  • 予後,プロモーターメチル化,変異分析を行った.

主要な成果:

  • PTPN6の発現の有意な変化が異なる癌のタイプで観察されました.
  • PTPN6発現の高さは,特に腎臓のクリア細胞癌,肝臓の肝細胞癌,直腸腺癌において,全生存率の低下と相関していた.
  • PTPN6は腫瘍細胞の増殖,移住,コロニー形成を促進し,腫瘍組織でメチル化が変化していることが観察されました.
  • 結論:

    • PTPN6は,がんにおける予後バイオマーカーおよび治療標的としての可能性を示しています.
    • 癌の進行におけるPTPN6の役割とその臨床的有用性を完全に理解するには,さらなる研究が必要である.